华润三九医药股份有限公司 is involved in the pharmaceutical industry, focusing on traditional Chinese medicine and related health products.

华润三九医药股份有限公司

Guangdong Investors

Investors Active in Beijing, Beijing

Shenzhen Investors

Private Guangdong Companies (Top 10K)

Huarun Sanjiu Pharmaceutical is engaged in pharmaceutical.

Shenzhen

Guangdong

China

Asia

Huarun Sanjiu Pharmaceutical

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:45 PM	4c57ac54
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:45 PM	3fb62fb3
crunchbase trigger	general	Nov 17, 2024 8:45 PM	ac5c15f1
crunchbase profile	general	Nov 17, 2024 9:05 PM	1175cc48
li profile	general	Nov 17, 2024 8:45 PM	5096d25a
translate crunchbase fundingrounds	general	Nov 17, 2024 9:30 PM	58f310b6
peers	general	Nov 17, 2024 8:45 PM	b5df8f07
news basic	general	Nov 17, 2024 8:45 PM	e3749ae4
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

0009

CN:COM:999

华润三九医药股份有限公司

Last Close

45.69

25/11 07:04

Market Cap

52.85B

Beta: -

Volume Today

9.99M

Avg: -